Inventor · disambiguated record
Jonathan Rosen
Also filed as: ROSEN JONATHAN · ROSEN JONATHAN I
7 granted patents·3 pending applications·87 citations·filing 1988–2025
81Inventor score
Technology areasA61K
Top patents by PatentIndex Score
10 records- 0189US11413309B2Compositions and methods for immune cell modulation in adoptive immunotherapiesFATE THERAPEUTICS INC·Filed 2017·Granted Aug 16, 2022·4 cites·26 claims
- 0289US11096964B2Compositions and methods for immune cell modulation in adoptive immunotherapiesFATE THERAPEUTICS INC·Filed 2017·Granted Aug 24, 2021·4 cites·31 claims
- 0383US11932870B2Compositions and methods for immune cell modulation in adoptive immunotherapiesFATE THERAPEUTICS INC·Filed 2017·Granted Mar 19, 2024·2 cites·14 claims
- 0482US4943628AHIV peptide-inducted T cell stimulationORTHO PHARMA CORP·Filed 1988·Granted Jul 24, 1990·77 cites·1 claims
- 0573US12419870B2Compositions and methods for immune cell modulation in adoptive immunotherapiesFATE THERAPEUTICS INC·Filed 2022·Granted Sep 23, 2025·0 cites·16 claims
- 0672US12281329B2Compositions and methods for immune cell modulation in adoptive immunotherapiesFATE THERAPEUTICS INC·Filed 2021·Granted Apr 22, 2025·0 cites·27 claims
- 0772US2024263135A1Compositions and methods for immune cell modulation in adoptive immunotherapiesFATE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0870US2025215396A1Compositions and methods for immune cell modulation in adoptive immunotherapiesFATE THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 0956US2024122948A1Compositions and methods for preventing and protecting against damage in cells and tissuesF3 PLATFORM BIOLOGICS INC·Filed 2021·Application pending·0 cites
- 1055US12036241B2Compositions and methods for immune cell modulation in adoptive immunotherapiesFATE THERAPEUTICS INC·Filed 2018·Granted Jul 16, 2024·0 cites·21 claims
Join the waitlist — get patent alerts
Get an alert when Jonathan Rosen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →